Novel anti-Helicobacter pylori agents

Bibliography

• MENDALL M, PAJARES-GARCIA J: Epidemiology and transmission of Helicobacter pylori. Curr. Opin. Gastroenterol (1995) 11 (Suppl. 0:1–4.
   Google Scholar
• CZINN SJ, NEDRUD JG: Irnmunopathology of Helico-bacter pylori infection and disease. Springer Semin. Immunopathol. (1997) 18(4):495–513.
   PubMedGoogle Scholar
• GRAHAM DY: Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology (1997) 113 (6) :1983–1991.
   PubMed Web of Science ®Google Scholar
• REALDI G, DORE MP, FASTAME L: Extradigestive manifestations of Helicobacter pylori infection - fact and fiction. Dig. Dis. sa (1999) 44(2):229–236.
   PubMedGoogle Scholar
• TELFORD JL, COVACCI A, RAPPUOLI R et al: Immuno-biology of Helicobacter pylori infection. Curr. Opin. Immunol. (1997) 9(4):498–503.
   PubMedGoogle Scholar
• ••Provides an in-depth review of the significance of the cagApathogenicity island in the pathogenesis of H. pylori infection and its implication in the development of an H pylori vaccine.
   Google Scholar
• BUCKLEY M, DELTENRE M: Therapy of Helicobacter infection. Curt-. Opin. Gastroenterof (1997) 13 (Suppl. 0:56–62.
   Google Scholar
• •A critical review of current knowledge of H. pylon pharma-cology and interactions, results from clinical trails on anti-Helicobacter therapy and the potential implication of the emergence of antibiotic resistance in clinical manage-ment of H pylori infection.
   Google Scholar
• DE BOER WA, TYTGAT GNJ: Treatment of Helicobacter infection. BM J(2000) 320 (7226):31–34.
   PubMedGoogle Scholar
• ••An excellent review on current treatment regimens in Hpylori infection that provides a basic framework on which treatment should be used in clinical practice.
   Google Scholar
• NEDRUD J, CZINN S: Helicobacter pylori. Curr. Opin.Gastroenterol. (1997) 13:71–78.
   Web of Science ®Google Scholar
• UNGE P: Antibiotic treatment of Helkobacter pyloriinfection. Curt-. Top. Microbiol. Immunol. (1999) 241:261–300.
   PubMedGoogle Scholar
• VAIRA D, ALT A, GATTA L et al: Treatment of Helico- pylori. Curr. Opin. Gastroenterol. (1998) 14 (Suppl. 1):S71–78.
   Google Scholar
• ••Provides a detailed summary and analysis of all the studiespublished from March 1997 to March 1998, in which different anti-H. pylori regimens have been used.
   Google Scholar
• BLANCHARD TG, CZINN SJ, NEDRUD JG: Host response vaccine development to Helicobacter pylori infection. Curr. Top. Microbiol. Immunol. (1999)241:181–213.
   PubMedGoogle Scholar
• ••Detailed review on current knowledge of the mechanism ofhost resistance to H pylon and the application of animal models in the development of H pylon vaccines.
   Google Scholar
• CZINN SJ, NEDRUD JG: Working towards a Helicobacter vaccine. Gastroenterology (1999) 116 (4) 990–994.
   PubMedGoogle Scholar
• •A commentary on the current status of, and future direction for, the development of H. pylori vaccination.
   Google Scholar
• KLEANTHOUS H, LEE CK, MONATH TP: Vaccine develop- against infection with Helicobacter pylori. Br. Med. Bull. (1998) 54(0:229–241.
   PubMedGoogle Scholar
• ••Provides preclinical data and the results of early stageclinical trials and directions for future research on H pylori vaccines.
   Google Scholar
• NEDRUD JG: Animal models for gastric Helkobacterimmunology and vaccine studies. FEMS Immunol Med. Microbiol. (1999) 24(2):243–250.
   PubMedGoogle Scholar
• ZEVERING Y, JACOB L, MEYER TF: Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut (1999) 45 (3):465–474.
   PubMedGoogle Scholar
• ••Provides a comprehensive review on naturally acquiredhuman immune responses against H pylori and its implica-tions for vaccine development.
   Google Scholar
• MICHETTI P: Vaccine against Helicobacter pylori: fact fiction? Gut (1997) 41 (6):728–730.
   PubMed Web of Science ®Google Scholar
• •Provides an excellent review on the rational for H pylori vaccination, what has been achieved and what remains to be done in the development of vaccination against H pylori infection.
   Google Scholar
• TOMB JF, WHITE O, KERLAVAGE AR et al.: The complete genome sequence of the gastric pathogen Helko-barter pylori. Nature (1997) 388(6642):539–547.
   PubMed Web of Science ®Google Scholar
• ALM RA, LING LSL, MOIR DT et al.: Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 397(6715):176–180.
   PubMedGoogle Scholar
• MARCHETTI M, ROSSI M, GIANNELLI V et al.: Protectionagainst Helicobacter pylori infection in mice by intragastric vaccination with H pylori antigens is achieved using a non-toxic mutant of E. co/Meat-labile enterotoxin (LT) as adjuvant. Vaccine (1998) 16 (1):33–37.
   PubMedGoogle Scholar
• LEE C K, SOIKE K, GIANNASCA P et al: Immunisation of monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helko- pylori. Vaccine (1999) 17 (23-24):3072–3082.
   PubMedGoogle Scholar
• ••The first study reporting that parenterally administrated Hpylori vaccination regimens either used alone or in combination with oral vaccine is effective in a non-human primate model and does not cause gastropathy.
   Google Scholar
• KIM SY, DOH HJ, JANG MH et al: Oral immunisation with Helicobacter pylori-loaded poly (D, L-lactide-co-glycolide) nanoparticles. Helicobacter (1999) 4(1)33–39.
   Google Scholar
• GOMEZ-DUARTE OG, LUCAS B, YAN ZX et al.: Protection of mice against gastric colonization by Helkobacter pylori by single oral dose immunisation with attenu-ated Salmonella typhimurium producing urease subunits A and B. Vaccine (1998) 16(5):460–471.
   PubMedGoogle Scholar
• GOMEZ-DUARTE OG, BUMANN D, MEYER TF: The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases. Vaccine (1999) 17(13-14):1667–1673.
   PubMedGoogle Scholar
• CORTHESY-THEULAZ IE, HOPKINS S, BACHMANN D et al: Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect. Immun. (1998) 66(2):581–586.
   PubMedGoogle Scholar
• BLANCHARD TG, CZINN SJ, REDLINE RW et al.: Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell. Immunol. (1999) 191 (1):74–80.
   PubMed Web of Science ®Google Scholar
• SUTTON P, WILSON J, KOSAKA T et al.: Therapeutic immunisation against Helicobacter pyloriinfection in the absence of antibodies. Immunol. Cell. Biol. (2000) 78 (1):28–30.
   PubMed Web of Science ®Google Scholar